PubMed COVID-19 Clinical Care
481 - 490 of 2196 results found
Revisiting a risk benefit analysis of mRNA COVID-19 vaccines during the omicron era
Description
No abstract
Remdesivir therapy for severe pediatric COVID-19 in Singapore: A single-center retrospective observational cohort study
Description
CONCLUSION: Our observational analysis was unable to detect any clear benefit of RDV in terms of reducing duration in HD/ICU. RDV was well-tolerated in children with severe COVID-19.
Retracted: New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis
Description
[This retracts the article DOI: 10.1155/2022/9604456.].
Risk of Severe COVID-19 and Protective Effectiveness of Vaccination Among Solid Organ Transplant Recipients
Description
CONCLUSIONS: SOTRs are at significantly higher risk for severe COVID-19 compared to non-SOTRs. Vaccination is effective in preventing the progression to severe COVID-19. Efforts should be made to improve vaccine uptake among SOTRs, while additional
Repurposing of Rutan showed effective treatment for COVID-19 disease
Description
Previously, from the tannic sumac plant (Rhus coriaria), we developed the Rutan 25 mg oral drug tablets with antiviral activity against influenza A and B viruses, adenoviruses, paramyxoviruses, herpes virus, and cytomegalovirus. Here, our re
Recurrent giant cell myocarditis following orthotopic heart transplant resulting in urgent redo orthotopic heart transplantation: a case report
Description
BACKGROUND: Giant cell myocarditis (GCM) is a severe and rapidly progressing condition that can lead to end-stage heart failure. We present a case of a 51-year-old male with a history of orthotopic heart transplantation (OHTx) for GCM, who
Recurrent intracranial anaplastic ependymoma with late-onset giant scalp metastasis
Description
KEY CLINICAL MESSAGE: Ependymomas are primary brain tumors that predominantly affect individuals between 0 and 4 years of age. Although ependymomas have a propensity for recurrence and the potential to spread within the central nervous system through
Retrospective review of the code status of individuals with Down syndrome during the COVID-19 era
Description
Code status is a label in the medical record indicating a patient's wishes for end-of-life (EOL) care in the event of a cardiopulmonary arrest. People with intellectual disabilities had a higher risk of both diagnosis and mortality from coronavirus
